BRAND_ANALYSIS#ASTRAZENECAHEALTH & PHARMA#23 OF 26 IN HEALTH & PHARMAALIGNED
AstraZeneca
· Public · Updated 09 Sep 2026 07:29 UTC
#1009 of 1208 overall by tension · #23 of 26 in Health & Pharma
8Aligned
The Aligned Power
Analysis
Pharma's bargain: 73 business points for 65 cultural ones, a 0.848 wiki_ratio proof that drug companies never become famous for the right reasons. Flat stock performance masks the reputational debt.
IN THE NEWS (100 articles this week)
Etcamah in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer - astrazeneca.com
AstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopes - CNBC
AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies - STAT